Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rapaport

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Thrombosis and Haemostasis|February 23, 1981
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factorB Osterud, C K Kasper, K K Lavine, et al.
American Journal of Clinical Pathology|January 1, 1992
Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombinS I Rapaport, A Zivelin, R A Minow, et al.
Blood|September 15, 1991
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reactionP M Sandset, B J Warn-Cramer, S L Maki, et al.
The Journal of Clinical Investigation|October 1, 1979
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XIIU Seligsohn, B Osterud, S F Brown, et al.
Blood|September 1, 1977
Hemophilia B: characterization of genetic variants and detection of carriersC K Kasper, B Osterud, J Y Minami, et al.
Blood|July 1, 1989
Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variablesT A Warr, B J Warn-Cramer, L V Rao, et al.
Blood|April 1, 1995
Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulantD T Le, J H Griffin, J S Greengard, et al.
Thrombosis and Haemostasis|March 1, 1997
Reliability of a modified tissue factor-dependent factor V assay for activated protein C resistant factor Va using a calcium-containing thromboplastinD T Le, K J Donnelly, N Wu, et al.
Journal of Microbiology and Biotechnology|December 7, 2007
A discrete mathematical model applied to genetic regulation and metabolic networksA J Asenjo, P Ramirez, I Rapaport, et al.
Annals of Internal Medicine|November 1, 1981
Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisoneK D Herbst, S I Rapaport, D G Kenoyer, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Thrombosis and Haemostasis|February 23, 1981
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factorB Osterud, C K Kasper, K K Lavine, et al.
American Journal of Clinical Pathology|January 1, 1992
Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombinS I Rapaport, A Zivelin, R A Minow, et al.
Blood|September 15, 1991
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reactionP M Sandset, B J Warn-Cramer, S L Maki, et al.
The Journal of Clinical Investigation|October 1, 1979
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XIIU Seligsohn, B Osterud, S F Brown, et al.
Blood|September 1, 1977
Hemophilia B: characterization of genetic variants and detection of carriersC K Kasper, B Osterud, J Y Minami, et al.
Blood|July 1, 1989
Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variablesT A Warr, B J Warn-Cramer, L V Rao, et al.
Blood|April 1, 1995
Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulantD T Le, J H Griffin, J S Greengard, et al.
Thrombosis and Haemostasis|March 1, 1997
Reliability of a modified tissue factor-dependent factor V assay for activated protein C resistant factor Va using a calcium-containing thromboplastinD T Le, K J Donnelly, N Wu, et al.
Journal of Microbiology and Biotechnology|December 7, 2007
A discrete mathematical model applied to genetic regulation and metabolic networksA J Asenjo, P Ramirez, I Rapaport, et al.
Annals of Internal Medicine|November 1, 1981
Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisoneK D Herbst, S I Rapaport, D G Kenoyer, et al.
Pageof 16